2nd Quarter - Report

MARS, INCORPORATED for MARS, INCORPORATED

Firm
Client
Income
—
Expenses
$340,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Immigration IMM

Support for legislative solutions for Deferred Action for Childhood Arrivals (DACA).

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS)

Food Industry (safety, labeling, etc.) FOO

Supporting FDA voluntary guidance on sodium; Supporting timely implementation of Nutrition Fact Panel; Preventative oral health; Food ingredient policy; Dietary guidelines; FMSA funding

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Agriculture, Dept of (USDA)

Agriculture AGR

Development of national standard on GMO labeling; Farm Bill policies, including sugar availability and policy reforms, and Supplemental Nutrition Assistance Program (SNAP) reauthorization; Trade issues, including NAFTA and other international trade issues; Appropriations funding for international aid and development programs, including ILAB and USAID; Funding for conservation programs.

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; Agriculture, Dept of (USDA)

Energy/Nuclear ENG

Issues related to energy savings and climate change, including U.S. support for Paris Climate Agreement and EPAs Clean Power Plan.

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: Agriculture, Dept of (USDA); SENATE; Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.